Cannabinoids

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has published a patent application owned by the Company for an invention entitled “Anti-Microbial Composition Comprising Cannabinoids,” EU Patent Publication Number 16815133.0. The patent application, […]

by

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has published a patent application owned by the Company for an invention entitled “Anti-Microbial Composition Comprising Cannabinoids,” EU Patent Publication Number 16815133.0. The patent application, […]

by

Introduction Cannabis is a psychoactive (hallucinatory) drug that consists of compounds known as cannabinoids. The primary effects of the plant are caused by the chemical delta-9-tetrahydrocannabinol (THC). Individual cannabinoid chemicals can be separated and purified from the marijuana plant, produced in the lab, or they may occur naturally (endogenous) as cannabinoids within the body. Multiple […]

by

Introduction Cannabis is a psychoactive (hallucinatory) drug that consists of compounds known as cannabinoids. The primary effects of the plant are caused by the chemical delta-9-tetrahydrocannabinol (THC). Individual cannabinoid chemicals can be separated and purified from the marijuana plant, produced in the lab, or they may occur naturally (endogenous) as cannabinoids within the body. Multiple […]

by

GW Pharmaceuticals’ cannabis-based epilepsy treatment, Epidiolex, scored a favorable review from FDA staff Tuesday, ahead of an advisory committee meeting scheduled later this week. The company provided “substantial evidence” of the drug’s effectiveness in treating two rare forms of epilepsy. “Although the review is still ongoing, the risk-benefit profile established by the data in the application […]

by

GW Pharmaceuticals’ cannabis-based epilepsy treatment, Epidiolex, scored a favorable review from FDA staff Tuesday, ahead of an advisory committee meeting scheduled later this week. The company provided “substantial evidence” of the drug’s effectiveness in treating two rare forms of epilepsy. “Although the review is still ongoing, the risk-benefit profile established by the data in the application […]

by

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has published a patent application owned by the Company for an invention entitled “Anti-Microbial Composition Comprising Cannabinoids,” EU Patent Publication Number 16815133.0. The patent application, […]

by

The California-headquartered firm was granted patents no. 9,044,390​ and 9,186,386​ from the US Patent and Trademark Office (USPTO), which it said would enable the application of bioactive cannabinoid molecules to dosage forms. Cure submitted​ a patent application for its oral film delivery technology – CureFilm –  in May last year. The film is administered on […]

by

Tewksbury, Mass., April 16, 2018 – PRESS RELEASE – Griffin will host an educational workshop for commercial marijuana and hemp growers on May 24 at the Crowne Plaza Denver Airport in Denver, Colo. The half-day program will focus on many aspects of crop fertility and nutrition delivery strategies, according to a press release. “The primary […]

by

WAUKEGAN – The Illinois Department of Public Health and Lake County Health Department are urging people to not use synthetic cannabinoids, often called Spice, K2, or fake weed. Dozens of people in Illinois, including two who died, have experienced severe bleeding, such as coughing up blood, blood in the urine, severe bloody nose, and/or bleeding […]

by

New research suggests that the condition, whose painful symptoms can be temporarily relieved with hot showers, isn’t as rare as once thought. Proponents of marijuana legalization have preached about its supposed medicinal benefits, while maintaining that it isn’t addictive, unlike other forms of drugs or intoxicants. However, recent reports have raised awareness of an increasingly […]

by

DENVER, Colorado—PRESS RELEASE—April 12, 2018—Hardy Boy Farms, one of Colorado’s largest greenhouse operators, and ebbu, one of the leading cannabinoid research companies in the world, are teaming up to push the frontiers of hemp research and cultivation in a new indoor facility, according to a press release. Hardy Boy Farms will provide ebbu with approximately […]

by